Godrej Agrovet Limited has announced its audited financial results for FY26, reporting robust performance with consolidated revenue surpassing ₹10,000 crore for the first time and all-time high profitability. The board meeting held on April 30, 2026, approved the financial results and recommended a final dividend of ₹11 per share. Following the results announcement, the company held a conference call with investors and analysts on May 4, 2026. The audio recording of this conference call is now available on the company's official website.

FY26 Consolidated Financial Performance

The company delivered strong financial performance in FY26, with consolidated revenue reaching ₹10,233 crore, representing a growth of 9.1% year-on-year. Profit after tax (PAT) stood at ₹440 crore, an increase of 13.9% compared to the previous year. EBITDA for the year was recorded at ₹936 crore with a margin of 9.1%, excluding non-recurring and exceptional items. On a reported basis, EBITDA stood at ₹969 crore with a margin of 9.5%, while reported PAT was ₹445 crore. The statutory auditors provided an unmodified opinion on both standalone and consolidated financial results.

Q4 FY26 Results

For the quarter ended March 31, 2026, the company reported consolidated revenue of ₹2,333 crore, up 9.3% year-on-year. Excluding non-recurring items, Q4 PAT stood at ₹74 crore, EBITDA at ₹173 crore with a margin of 7.4%, and profit before tax at ₹87 crore. On a reported basis, Q4 EBITDA was ₹207 crore (+29.5%), PBT was ₹120 crore (+61.9%), and PAT was ₹102 crore (+54.7%). The standalone profit before tax for Q4 FY26 was ₹81.45 crore with total revenue of ₹1,725.06 crore.

CEO Commentary on Performance

Commenting on the performance, Mr. Sunil Kataria, Chief Executive Officer & Managing Director, highlighted that FY26 marked a strong year of delivery with consolidated revenues surpassing ₹10,000 crore, growing by 9% year-on-year, while profitability registered a robust 17% growth. He emphasized the strength of the company's growth strategy of moving towards a value-added portfolio, disciplined execution and sharp focus on improving the quality of earnings. The year was led by exceptional performance in Oil Palm and Animal Nutrition businesses, with Oil Palm delivering outstanding performance through strong volume growth, peak oil recovery and margin expansion.

Segment-Wise Performance

Animal Nutrition emerged as the largest revenue contributor at 46.43% of total revenue, with sales volume growing 11.6% year-on-year to 16,46,545 tons. The segment reported revenue of ₹4,941 crore and segment result of ₹347 crore. Oil Palm business delivered exceptional performance with segment result growing 67.9% to ₹384 crore, contributing 40.12% to total segment results. Crop Care reported revenue of ₹772 crore with segment result of ₹224 crore, though performance was impacted by adverse weather, sharp acreage declines in key crops, regulatory disruptions and channel inventory build-up. Creamline Dairy revenues remained broadly flat at ₹1,589 crore, with EBITDA impacted by elevated milk procurement prices. Godrej Foods Limited (GFL) reported revenues of ₹768 crore with EBITDA of ₹50 crore, as the company consciously reduced exposure to the volatile live-bird category, with branded revenue salience increasing to over 80% in FY26.

Astec LifeSciences

Astec LifeSciences delivered a strong turnaround in FY26, with revenues growing 17.5% to ₹448 crore and achieving EBITDA break-even at ₹1 crore, compared to an EBITDA loss of ₹61 crore in FY25. Improved volumes, better realizations and higher capacity utilization across Enterprise and CDMO businesses supported the recovery. In Q4 FY26, revenues grew 32.7% year-on-year to ₹159 crore with EBITDA of ₹12 crore.

Joint Venture – ACI Godrej Agrovet Private Ltd

The joint venture reported revenues (100% basis) of BDT 2,045 crore in FY26, compared to BDT 2,216 crore in FY25, a decline of 7.7% year-on-year. Q4 FY26 revenues stood at BDT 511 crore, up 8.4% year-on-year.

Working Capital Optimization and ROCE

The company achieved significant working capital optimization, with average net working capital (NWC) reducing to ₹686 crore in FY26 from ₹988 crore in FY25 and ₹1,172 crore in FY24. Average NWC in days improved to 25 days in FY26 from 39 days in FY25 and 45 days in FY24, translating to an improved return on capital employed (ROCE) of 20% in FY26, up from 16% in FY25 and 13% in FY24.

Final Dividend and AGM

The board has recommended a final dividend at the rate of 110% on equity share capital, translating to ₹11.00 per equity share of face value ₹10.00 each for FY26. This dividend recommendation is subject to shareholder approval at the upcoming 35th Annual General Meeting scheduled for August 5, 2026, at 4:00 p.m. via video conference.

ESG Initiatives and Sustainability

On the ESG front, Godrej Agrovet maintained its water-positive status with 14x water conservation, sequestering 29.59 million m³ of water against a consumption of 2.0 million m³. The company achieved a 12.4% reduction in Scope 1 & 2 GHG emissions and maintained a renewable energy portfolio of 78.9%, with solar rooftops installed at 20+ manufacturing sites generating approximately 13,500 MWh cumulatively in FY26. The company received an "A-" leadership band rating from CDP for Climate & Forest disclosure for the second consecutive year, and a "Gold" rating from EcoVadis, placing its agrochemical business among the top 5% of companies globally. Godrej Agrovet is the first agri company in India to have an approved science-based emission reduction target aligned to WB2DS, committing to a 37.5% Scope 1+2 GHG emission reduction by FY35 from a baseline year of FY20.

Shareholding Pattern

As of March 31, 2026, promoters held 67.7% of the company's shares, while other investors accounted for 18.5%. Domestic institutional investors (DII) held 7.5% and foreign institutional investors (FII) held 6.3%. Major investors include Temasek, Vanguard, LIC of India, Nippon Mutual Fund, FSSA Investment Managers, Franklin India Mutual Fund, UTI Mutual Fund, Kotak Mutual Fund, Tata Mutual Fund, Motilal Oswal Mutual Fund, and Franklin Templeton Investments.

Employee Stock Option Activities

The Nomination and Remuneration Committee approved the allotment of 30,973 equity shares under the Employees Stock Grant Scheme 2018, realizing ₹3,09,730. Additionally, the committee granted 50,507 stock options under Grant-9 at an exercise price of ₹10.00 per option, while 7,518 stock options lapsed due to employee cessation. Following the allotment, the paid-up share capital increased to ₹192,35,99,670.

Pursuant to SEBI LODR Regulations, the company published its audited financial results in Financial Express, Business Standard, Loksatta, and Mumbai Lakshdeep on May 1, 2026.

Godrej Agrovet Limited has announced a conference call with investors and analysts to discuss its Q4FY26 financial results. The call is scheduled for Monday, May 4, 2026 at 3:00 p.m. IST and will be hosted by ICICI Securities.

Regulatory Filing Details

The company filed the official intimation with both BSE Limited and National Stock Exchange of India Limited on April 24, 2026, in compliance with Regulation 30 requirements. The filing was signed by Vivek Raizada, Head – Legal & Company Secretary & Compliance Officer (ACS - 11787), confirming adherence to regulatory disclosure norms.

Leadership Participation

The conference call will feature participation from the company's senior leadership team. Key executives who will represent Godrej Agrovet during the discussion include:

• Mr. Nadir Godrej – Chairman
• Mr. Burjis Godrej – Chairman Designate
• Mr. Sunil Kataria – CEO and Managing Director
• Mr. S. Varadaraj – Chief Financial Officer
• Mr. Arijit Mukherjee – Executive Director and Chief Operating Officer (Astec LifeSciences)

Access Information

The company has provided multiple access options for participants to join the Q4FY26 results conference call:

International Toll-Free Numbers

Contact Information

ICICI Securities has designated several coordinators for the conference call. Mr. Jaideep Goswami, Head of Equities, serves as the primary call coordinator and can be reached at jaideep.goswami@icicisecurities.com . Additional contacts include:

• Mr. Probal Sen: +91 22 6807 7274, probal.sen@icicisecurities.com
• Mr. Hardik Solanki: +91 22 6807 7386, solanki.hardik@icicisecurities.com

For clarifications, participants can contact Mr. Rushad Kapadia (+91 22 6807 7334), Ms. Seema Sehgal (+91 9871116926), or Ms. Minali Ginwala (+91 22 6807 7454).

Company Information

Godrej Agrovet Limited is headquartered at Godrej One, 3rd Floor, Pirojshanagar, Eastern Express Highway, Vikhroli (E), Mumbai 400 079. The conference call details are also available on the company's official website at www.godrejagrovet.com .